146 related articles for article (PubMed ID: 25760819)
1. Enoyl-coenzyme A hydratase short chain 1 silencing attenuates the proliferation of hepatocellular carcinoma by inhibiting epidermal growth factor signaling in vitro and in vivo.
Lin BY; Xiao CX; Zhao WX; Xiao L; Chen X; Li P; Wang XM
Mol Med Rep; 2015 Jul; 12(1):1421-8. PubMed ID: 25760819
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of Akt activity.
Zhu XS; Dai YC; Chen ZX; Xie JP; Zeng W; Lin YY; Tan QH
Crit Rev Eukaryot Gene Expr; 2013; 23(3):275-82. PubMed ID: 23879543
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of enoyl coenzyme A hydratase 1 expression in colorectal cancer cells using small interfering RNA inhibits cell proliferation and migration.
Zhao QM; Kuang F; Wu H; Zhang YH
Mol Med Rep; 2015 Jul; 12(1):470-4. PubMed ID: 25739098
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of enoyl coenzyme A hydratase short chain 1 expression in gastric cancer cells inhibits cell proliferation and migration in vitro.
Zhu XS; Gao P; Dai YC; Xie JP; Zeng W; Lian QN
Cell Mol Biol Lett; 2014 Dec; 19(4):576-89. PubMed ID: 25338767
[TBL] [Abstract][Full Text] [Related]
5. ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells.
Xiao CX; Yang XN; Huang QW; Zhang YQ; Lin BY; Liu JJ; Liu YP; Jazag A; Guleng B; Ren JL
Cancer Lett; 2013 Mar; 330(1):67-73. PubMed ID: 23178449
[TBL] [Abstract][Full Text] [Related]
6. Silencing ECHS1 attenuates the proliferation and induces the autophagy of hepatocellular carcinoma via impairing cell metabolism and activating AMPK.
Xu WJ; Chen LG; Chen X; Liu YS; Zheng TH; Song JJ; Xu W; Li P; Zhang MQ; Xiao CX; Guleng B; Ren JL
Neoplasma; 2015; 62(6):872-80. PubMed ID: 26458321
[TBL] [Abstract][Full Text] [Related]
7. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
8. Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.
Pu J; Wu X; Wu Y; Shao Z; Luo C; Tang Q; Wang J; Wei H; Lu Y
Aging (Albany NY); 2021 Mar; 13(8):12207-12223. PubMed ID: 33952719
[TBL] [Abstract][Full Text] [Related]
9. Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients.
Zhang YK; Qu YY; Lin Y; Wu XH; Chen HZ; Wang X; Zhou KQ; Wei Y; Guo F; Yao CF; He XD; Liu LX; Yang C; Guan ZY; Wang SD; Zhao J; Liu DP; Zhao SM; Xu W
Nat Commun; 2017 Sep; 8(1):464. PubMed ID: 28878358
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
11. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
12. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
[TBL] [Abstract][Full Text] [Related]
13. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
14. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
Qu YY; Zhao R; Zhang HL; Zhou Q; Xu FJ; Zhang X; Xu WH; Shao N; Zhou SX; Dai B; Zhu Y; Shi GH; Shen YJ; Zhu YP; Han CT; Chang K; Lin Y; Zang WD; Xu W; Ye DW; Zhao SM; Zhao JY
Cancer Res; 2020 Jan; 80(2):319-333. PubMed ID: 31690668
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195.
Liu D; Zhu Y; Pang J; Weng X; Feng X; Guo Y
J Cell Biochem; 2018 Feb; 119(2):1368-1380. PubMed ID: 28722813
[TBL] [Abstract][Full Text] [Related]
17. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
18. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
